Wealth Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-439
Closed -$216K 116
2026
Q1
$216K Buy
+439
New +$238K 0.2% 82
2025
Q2
Sell
-498
Closed -$248K 150
2025
Q1
$248K Sell
498
-198
-28% -$107K 0.16% 133
2024
Q4
$362K Buy
696
+224
+47% +$123K 0.23% 95
2024
Q3
$292K Sell
472
-144
-23% -$85.2K 0.2% 116
2024
Q2
$341K Buy
616
+3
+0.5% +$1.72K 0.24% 103
2024
Q1
$356K Buy
+613
New +$344K 0.27% 94

Other funds holding TMO

Wealth Group's TMO Position: Q2 2026 in Review

Wealth Group sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 439 shares — an estimated $216K sold.

Wealth Group first reported a position in TMO in Q1 2024 and held it in 6 quarters. The position peaked at $362K in Q4 2024. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Wealth Group reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Wealth Group sold 439 Thermo Fisher Scientific shares in Q2 2026, an estimated $216K.
  • Wealth Group first reported a position in Thermo Fisher Scientific in Q1 2024 and held it in 6 quarters.
  • Wealth Group's Thermo Fisher Scientific position peaked at $362K in Q4 2024.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Wealth Group's 13F filing for Q2 2026, filed 21 Jul 2026.